Survival after percutaneous coronary intervention and coronary artery bypass grafting in a single centre

References

• Yusuf S, Zucker D, Peduzz P, Fisher LD, Takaro T, Kennendy JW, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trial by the Coronary Artery Bypass graft Surgery Trialists Collaboration. Lancet. 1994; 344: 563–70
   PubMed Web of Science ®Google Scholar
• Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg. 2006; 82: 1420–9
   PubMed Web of Science ®Google Scholar
• Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary agioplasty versus medical treatment for non-acute coronary heart disease: Meta-analysis of randomised controlled trials. BMJ. 2000; 3213: 73–7
   Google Scholar
• Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KAA, Julian DG, et al. for the Second Randomized Intervention treatment of Angina (RITA-2) Trial Participants. J Am Coll Cardiol. 2003; 42: 1161–70
   PubMed Web of Science ®Google Scholar
• Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: A meta-analysis. Circulation. 2005; 111: 2906–12
   PubMed Web of Science ®Google Scholar
• Dzavik V, Ghali WA, Norris C, Mitchell LB, Koshal A, Saunders LD, et al. for the APPROACH Investigators. Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: A report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Am Heart J. 2001; 142: 119–26
   PubMed Web of Science ®Google Scholar
• Brener SJ, Lytle BW, Casserly IP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary disease and high-risk features. Circulation. 2004; 109: 2290–5
   PubMed Web of Science ®Google Scholar
• Malenka DJ, Leavitt BJ, Hearne MJ, Robb JF, Baribeau YR, Ryan TJ, . for the Northern New England Cardiovascular Disease Study Group, et al. Comparing long-term survival of patients with multivesse coronary disease after CABG or PCI: Analysis of BARI-like patients in Northern New England. Circulation. 2005;112;371–6.
   Google Scholar
• Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary-artery bypass grafting versus stentimplantation. New Engl J Med. 2005; 352: 2174–83
   PubMed Web of Science ®Google Scholar
• The Bypass Angioplasty Revasularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217–25.
   PubMed Web of Science ®Google Scholar
• The BARI Investigators. Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 2000;35:1122–9.
   PubMed Web of Science ®Google Scholar
• King SB, 3rd, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS, for the Emory Angioplasty versus Surgery Trial (EAST) Investigators. Eight-year mortality in the Emory Angioplasty versus surgery trial (EAST). J Am Coll Cardiol. 2000;35:1116–21.
   PubMed Web of Science ®Google Scholar
• Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier IJRM, Schønberger JPAM, et al. for the Arterial revascularization Therapies study group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001; 344: 1117–24
   PubMed Web of Science ®Google Scholar
• Stables RH. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with mutivessel coronary artery disease (the Stent or Surgery trial): A randomized controlled trial. Lancet. 2002; 360: 965–70
   PubMed Web of Science ®Google Scholar
• Rodriguez AE, Baldi J, Pereira CF, Navia J, Alemparte MR, Delacasa A, et al. on behalf of the ERACI II investigators. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol. 2005; 46: 582–8
   PubMed Web of Science ®Google Scholar
• Serruys PW, Ong ATL, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJRM, et al. Five-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. J Am Coll Cardiol. 2005; 46: 575–81
   PubMed Web of Science ®Google Scholar
• Hoffman SN, TenBrook JA, Jr, Wolf MP, Stephen G, Pauker SG, Salem DN, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: One- to eight-year outcomes. J Am Coll Cardiol. 2003; 41: 1293–304
   PubMed Web of Science ®Google Scholar
• Guyton RA. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease. Ann Thorac Surg. 2006; 81: 1949–57
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984; 79: 516–24
   Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The central role of propensity score in observational studies for causal effects. Biometrika. 1983; 70: 41–55
   Web of Science ®Google Scholar
• Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R, et al. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: Comparison with the randomized trial; BARI Investigators. Circulation. 2000; 101: 2795–802
   PubMed Web of Science ®Google Scholar
• Detre KM, Guo P, Holubkov R, Califf RM, Sopko G, Bach R, et al. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1999; 99: 633–40
   PubMed Web of Science ®Google Scholar